|
AU2015335599A1
|
|
Preparations of meta-iodobenzylguanidine and precursors thereof
|
|
EP3193914A1
|
|
Organ protection in psma-targeted radionuclide therapy of prostate cancer
|
|
AU2014337055A1
|
|
Methods of using SPECT/CT analysis for staging cancer
|
|
EP2943227A1
|
|
Triazine based radiopharmaceuticals and radioimaging agents
|
|
AU2013207486A1
|
|
Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase IX
|
|
EP3505192A1
|
|
Radiolabeled prostate specific membrane antigen inhibitors
|
|
AU2012200218A1
|
|
Technetim-and rhenium-bis(heteroaryl) complexes, and methods of use thereof
|
|
US2010303725A1
|
|
Technetium- and Rhenium-Bis(heteroaryl) Complexes, and Methods of Use Thereof
|
|
HUE029940T2
|
|
Bis(imidazolyl)compounds and radionuclide complexes
|
|
EP2706057A1
|
|
Bis(imidazolyl)compounds and radionuclide complexes
|
|
BRPI0919818A2
|
|
selective seprase inhibitors
|
|
CN102202503A
|
|
Pharmaceutical composition of a radioiodinated benzamide derivative and methods of making the same
|
|
US2011124948A1
|
|
Radiolabeled treatment infusion system, apparatus, and methods of using the same
|
|
AU2009204133A1
|
|
Inhibitors of carbonic anhydrase IX
|
|
US2009180951A1
|
|
Inhibitors of integrin vla-4
|
|
EP2185221A1
|
|
Infusion and transfer system for use with radioactive agents
|
|
CA2669127A1
|
|
Heterodimers of glutamic acid
|
|
BRPI0716368A2
|
|
Radio-imaging Portions Coupled to Peptidase Binding Portions for Imaging Tissues and Peptidases Expressing Organs
|
|
CN1972719A
|
|
Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof
|
|
US2006093552A1
|
|
Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof
|
